Cardinal Health, Inc. (NYSE:CAH) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Wednesday.

CAH has been the topic of several other reports. UBS AG restated a “neutral” rating and issued a $76.00 price objective (down from $79.00) on shares of Cardinal Health in a research report on Thursday, August 3rd. Credit Suisse Group reaffirmed an “outperform” rating and issued a $87.00 target price (up previously from $81.00) on shares of Cardinal Health in a research note on Thursday, July 13th. Barclays PLC reaffirmed an “overweight” rating and issued a $82.00 target price (down previously from $88.00) on shares of Cardinal Health in a research note on Saturday, April 22nd. William Blair lowered Cardinal Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 19th. Finally, Jefferies Group LLC began coverage on Cardinal Health in a research note on Wednesday, May 17th. They issued a “hold” rating and a $77.00 target price for the company. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company’s stock. Cardinal Health presently has an average rating of “Hold” and a consensus price target of $80.46.

Cardinal Health (NYSE CAH) traded down 0.63% during midday trading on Wednesday, hitting $66.01. 2,600,249 shares of the stock were exchanged. The company has a market capitalization of $20.86 billion, a P/E ratio of 16.38 and a beta of 0.80. The company’s 50 day moving average is $74.55 and its 200 day moving average is $76.72. Cardinal Health has a 1-year low of $62.70 and a 1-year high of $84.88.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. Cardinal Health’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.14 earnings per share. Analysts predict that Cardinal Health will post $4.97 earnings per share for the current fiscal year.

WARNING: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/16/cardinal-health-inc-cah-stock-rating-lowered-by-bidaskclub.html.

Several hedge funds have recently added to or reduced their stakes in CAH. Advisory Services Network LLC bought a new stake in Cardinal Health during the first quarter worth $120,000. Bronfman E.L. Rothschild L.P. raised its stake in Cardinal Health by 31.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after buying an additional 382 shares during the period. JFS Wealth Advisors LLC raised its stake in Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after buying an additional 244 shares during the period. Dupont Capital Management Corp bought a new stake in Cardinal Health during the second quarter worth $164,000. Finally, First Personal Financial Services raised its stake in Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares during the period. 86.41% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.